Outlook Therapeutics Inc (OTLK)

[H2R]

Hi Thermo,

Thanks for sharing your thoughts and I do appreciate them :) !

If I may, I am not seeing H.C.W. shorting OTLK. The reason for this is their Buy Recommendation date May 16h, 2023:

As of May 11, 2023, the average one-year price target for Outlook Therapeutics is 6.74. The forecasts range from a low of 4.04 to a high of $10.50. The average price target represents an increase of 461.60% from its latest reported closing price of 1.20.

* https://www.nasdaq.com/articles/hc-wainwright-co.-reiterates-outlook-therapeutics-otlk-buy-recommendation


OTLK also presented at the HCW BioConnect conf:

* https://www.marketscreener.com/quote/stock/OUTLOOK-THERAPEUTICS-INC-57291679/news/Outlook-Therapeutics-to-Present-at-the-H-C-Wainwright-BioConnect-Investor-Conference-43680120/

There could be a number of reasons to switch to BTIG. OTLK used BTIG earlier, as an advisor. The following is from Dec 23rd, 2022

M.S. Howells & Co. acted as placement agent with respect to certain accredited investors in the offering. BTIG, LLC acted as exclusive financial advisor to Outlook Therapeutics in connection with the offering. BTIG, LLC is not acting as an underwriter or a placement agent in connection with the offering and, accordingly, BTIG, LLC is neither purchasing securities nor offering securities to the public in connection with the offering.

https://ir.outlooktherapeutics.com/news-releases/news-release-details/outlook-therapeutics-announces-25-million-registered-direct

I would not be surprised if BTIG put their best foot forward to win the account. It could also be that the amount of shares to sell in the latest agreement better fit BTIG.

If I may:
* What makes you think HCW would facilitate shorting given their own recommendations?
* What impact do you think an HCW driven shorting could have on the PPS or other operational aspects?

Thank you Thermo!

Best of luck with your investments!